Download presentation
Published byMarina Frakes Modified over 10 years ago
1
Meg Fisher, MD Medical Director, The Children’s Hospital
Vaccine Preventable Diseases and the Healthcare Provider Meg Fisher, MD Medical Director, The Children’s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ
2
I will be mentioning off label uses of vaccines.
Disclosures I have no disclosures. I will be mentioning off label uses of vaccines.
3
List and discuss vaccines needed to prevent these diseases
Objectives Describe the vaccine preventable diseases that relate to the healthcare provider in the acute care setting List and discuss vaccines needed to prevent these diseases
4
Immunization Public health success story
Rates of all vaccine preventable illnesses have plummeted: Smallpox, diphtheria, tetanus, polio, measles, mumps, rubella, Haemophilus influenzae type b almost gone in the US
5
Infection is just a plane ride away!
Immunization Rates Don’t get complacent! Infection is just a plane ride away!
6
Identify these infections
Test your knowledge Identify these infections
7
Courtesy of the American Academy of Pediatrics
and the Centers for Disease Control and Prevention
8
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
9
Courtesy of his mother
10
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
11
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
12
Courtesy of eMedicine and ADAM
13
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
14
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
15
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
16
Centers for Disease Control and Prevention
Courtesy of the Centers for Disease Control and Prevention
17
Courtesy of the WHO and the Centers for Disease Control and Prevention
18
Courtesy of PA AAP
19
Courtesy of the WHO and the Centers for Disease Control and Prevention
20
Courtesy of the Centers for Disease Control and Prevention
21
Vaccine Preventable Diseases
Hepatitis B, rotavirus, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, Streptococcus pneumoniae, influenza, measles, mumps, rubella, varicella, hepatitis A, Neisseria meningitidis, human papillomavirus
22
Shortages? Major dilemma for practitioners
Distribution always a problem Web site for vaccine shortages: None currently
23
Vaccine Safety www.cdc.gov/vaccinesafety
Concerns are limiting vaccine use Rates in New Jersey have fallen dramatically
24
Immunization Safety Starts during development
Continues through all stages of licensure and during postlicensure use Vaccine adverse event reporting system Vaccine safety datalink Clinical immunization safety assessment
25
National Vaccine Injury Compensation Program
Established by National Childhood Vaccine Injury Act No fault compensation program Report suspected adverse events to VAERS
26
Advisory Committee on Immunization Practices
Provides advice for CDC Multidisciplinary panel with many liaisons Pediatricians well represented
28
Hepatitis B vaccine All providers with blood exposure
Three doses: 0, 1, 6 mo Titers to prove response to vaccine If < 10 mIU/ml, repeat series and titer Older less likely to respond
29
Exposure to HBsAg + Blood
Immune: education re preventing exposures Non-responder or not immunized: HBIG plus education re preventing exposures Immunized but not tested: test and give HBIG if negative
30
Hepatitis B Vaccine New dilemma:
Adolescents immunized as children may have low or no antibody levels at entry to college, nursing schools, medical schools Consider giving one dose and repeat titer If negative, finish the series and repeat titer
31
“I had a little bird. His name was Enza. I opened the window.
And in flew Enza.” A chant popular during the influenza pandemic of 1918
32
Recommendations All people 6 months of age and older
Healthcare personnel: mandates recommended by IDSA, PIDS, AAP and others Formulated yearly on best guess Two A strains, one B Start when you get it and continue all season
33
Influenza Vaccines A/California/7/2009 (H1N1)-like
A/Perth/16/2009 (H3N2)-like B/Brisbane/60/2008-like Inactivated, live cold adapted
34
Influenza Vaccine Schedule
Yearly – start when you get it Children under 3 years: lower dose Child under 9: two doses first season* Contraindicated in persons with anaphylaxis to chicken or eggs
35
Measles, Mumps, Rubella Measles and rubella no longer endemic in the United States Mumps outbreak over in NJ MMRV combination – more fever We should be immune: born before 1957, + titer or received 2 doses of vaccine
36
Varicella Vaccine Prevents serious illness Outbreaks persist
Second dose now recommended for all Routine at 4-5 years, MMRV Catch up for older
37
Zoster vaccine Zostavax Approved May 2006
Age 60 and above; now 50 and above Protect yourself when the time comes
38
Tdap: Boostrix, Adacel Tetanus, diphtheria, pertussis booster
For teens (both) and adults (Adacel) Licensed in spring 2005 Should alter epidemiology and protect infants Protect yourself and your staff
39
Targeted adults Anyone caring for young infants
Cocoon the infants by immunizing contacts Healthcare people Pregnant women in late 2nd, 3rd trimester Give to the entire household, preferably before delivery
40
Latest from ACIP Off label use of the vaccine:
Use Tdap for incompletely vaccinated children down to age 7 years Use Tdap in adults over 65 years Pregnant women in the 2nd or 3rd trimester Tdap at any interval following T or Td
41
Meningococcal vaccines
Polysaccharide vaccine rarely used today Conjugate vaccines originally recommended: Adolescents age yr (pre-teen visit) Adolescents age 15 yr (high school entry) Incoming college freshmen in dorms High risk groups
42
Latest Recommendations
Booster dose for adolescents: age 16 or years after the first dose Highest risk: initial 2 dose series followed by booster doses every 5 years At risk healthcare: microbiologists only
43
Rotavirus vaccines The old: Rotashield Rhesus rotavirus reassortant
Licensed 8/98 Withdrawn 10/99 Intussusception risk < 1/10,000
44
Rotavirus vaccines The new: RotaTeq, Rotarix
RotaTeq: human-bovine reassortant Well tolerated, effective, over 70,000 Licensed February 2006 Rotarix: monovalent, human strain Licensed and used outside US
45
Safety Issues Porcine circoviruses: no harm
Rates of intussusception among vaccine recipients closely studied; post-licensure studies results vary Benefits greatly outweigh risks
46
Haemophilus influenzae type b
Disease dramatically decreased in US Conjugate vaccine eliminates carriage Keep vaccinating!
47
Streptococcus pneumoniae
Dramatic decrease in US since PCV7 Decrease in adult disease as well PCV13 now replaces PCV7 Polysaccharide vaccine PPSV23 for high risk children and adults
48
Polio Virus Vaccine Polio eliminated from most of the world
But in 2010 spread to over a dozen countries Live oral: not in US since 2000, source of some recent outbreaks Inactivated: safe effective, 4 dose series, last/extra dose at 4 to 6 years
49
Hepatitis A Vaccines Inactivated Two doses, 6 months apart
Prior to 2006: at risk or in high incidence state Now: at risk and all children at age 1 Catch up is reasonable
50
HPV Vaccines Virus-like particles genetically engineered
Quadravalent and bivalent vaccines Well tolerated and immunogenic Three dose series Universal for girls; permissive for boys
51
Websites www.aap.org www.cdc.gov www.immunizationinfo.org
53
Smiling is a contagious condition!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.